Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

1.2%

1 terminated/withdrawn out of 84 trials

Success Rate

94.4%

+7.9% vs industry average

Late-Stage Pipeline

14%

12 trials in Phase 3/4

Results Transparency

0%

0 of 17 completed trials have results

Key Signals

24 recruiting

Enrollment Performance

Analytics

N/A
22(37.3%)
Phase 2
15(25.4%)
Phase 1
10(16.9%)
Phase 3
8(13.6%)
Phase 4
4(6.8%)
59Total
N/A(22)
Phase 2(15)
Phase 1(10)
Phase 3(8)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (84)

Showing 20 of 84 trials
NCT07168980Phase 2Recruiting

Chemotherapy With Rituximab for Aggressive B-NHL in Children and Adolescents

Role: collaborator

NCT07593846Phase 3Not Yet Recruiting

The Comparison Between DEDTI BR and T/E BR

Role: collaborator

NCT04276532Not ApplicableActive Not Recruiting

Sentinel Lymph Node Sampling for Patients With Middle-high Risk Endometrial Cancer Confined to the Uterus

Role: collaborator

NCT07539545Not ApplicableNot Yet Recruiting

The Comparison Between M-E-BCS and C-O-BCS.

Role: collaborator

NCT07508072Not ApplicableNot Yet Recruiting

Comparison of High-Definition Electronic Magnifying Endoscopy With Image-Enhanced Technology Versus Colposcopy in the Detection of Cervical and Vaginal Lesions

Role: lead

NCT07264192Phase 1Completed

A Study of HS-10518 in Healthy Adult Premenopausal Females in China

Role: lead

NCT02405676Phase 2Active Not Recruiting

BNHL-2015 for Children or Adolescents in China

Role: collaborator

NCT06563245Phase 2Recruiting

Brentuximab Vedotin for Newly Diagnosed cHL in Chinese CAYA Based on PET/CT Assessment

Role: collaborator

NCT05681260Phase 3Recruiting

Capizzi Escalating Methotrexate Versus High Dose Methotrexate in Children With Newly Diagnosed T-cell Lymphoblastic Lymphoma (T-LBL)

Role: collaborator

NCT04881838Phase 3Active Not Recruiting

CCCG-ALCL-2020 for Chinese Children and Adolescents With Newly Diagnosed High-risk ALCL

Role: collaborator

NCT02845882Phase 3Active Not Recruiting

LBL-2016 for Children or Adolescents in China

Role: collaborator

NCT07457008Phase 1Completed

Tolerability & Pharmacokinetics of Ginkgolide B Injection: Single- and Multiple-Ascending Doses in Healthy Subjects

Role: lead

NCT07431060Not ApplicableRecruiting

Modified LCH-III Regimen With or Without Luvometinib for Multisystem Pediatric Langerhans Cell Histiocytosis

Role: lead

NCT05692011Recruiting

AN69ST Verse PS in CBP in Septic Children

Role: collaborator

NCT07369284Phase 2Not Yet Recruiting

Melatonin for Glycemic Control in Gestational Diabetes Mellitus

Role: collaborator

NCT07371182Not ApplicableRecruiting

Luvometinib in Pediatric SS-LCH With Special-site Single/Multifocal Bone Lesions

Role: lead

NCT04339166Not ApplicableCompleted

Embryo Selection by Noninvasive Preimplantation Genetic Test

Role: collaborator

NCT07269574Not Yet Recruiting

Impact of Dietary Patterns on Prognosis of Ovarian Cancer Patients During PARPi Maintenance

Role: collaborator

NCT07201259Not Yet Recruiting

Exploring Gut Microbiome Differences in Female Cancer Patients With Varied Ovarian Function and Fertility Outcomes Following Immune Checkpoint Inhibitor Therapy

Role: lead

NCT06663553Not ApplicableNot Yet Recruiting

Comparing the Efficacy of TU-LESS and vNOTES for Hysterectomy of Enlarged Uterus

Role: lead